|
Cardiolipins
|
D002308 |
[Acidic phospholipids composed of two molecules of phosphatidic acid covalently linked to a molecule of glycerol. They occur primarily in mitochondrial inner membranes and in bacterial plasma membranes. They are the main antigenic components of the Wassermann-type antigen that is used in nontreponemal SYPHILIS SERODIAGNOSIS.
] |
|
Cardiologists
|
D000072096 |
[Qualified medical professionals who specialize in preventing and treating disorders of the heart and CARDIOVASCULAR SYSTEM.
] |
|
Cardiology
|
D002309 |
[The study, diagnosis, and treatment of diseases of the blood vessels (VASCULAR DISEASES) and vessels of lymphatic system (LYMPHATIC DISEASES).
, The study of the heart, its physiology, and its functions.
] |
|
Cardiology Service, Hospital
|
D016507 |
[The hospital department responsible for the administration and provision of diagnostic and therapeutic services for the cardiac patient.
] |
|
Cardiomegaly
|
D006332 |
[Enlargement of the HEART due to chamber HYPERTROPHY, an increase in wall thickness without an increase in the number of cells (MYOCYTES, CARDIAC). It is the result of increase in myocyte size, mitochondrial and myofibrillar mass, as well as changes in extracellular matrix.
, Enlargement of the HEART, usually indicated by a cardiothoracic ratio above 0.50. Heart enlargement may involve the right, the left, or both HEART VENTRICLES or HEART ATRIA. Cardiomegaly is a nonspecific symptom seen in patients with chronic systolic heart failure (HEART FAILURE) or several forms of CARDIOMYOPATHIES.
] |
|
Cardiomegaly, Exercise-Induced
|
D059267 |
[Non-pathological heart enlargement and other remodeling in cardiac morphology and electrical circuitry found in individuals who participate in intense repeated exercises.
] |
|
Cardiometabolic Risk Factors
|
D000083202 |
[A cluster of personal behavior or lifestyle, environmental exposure, inborn or inherited conditions and characteristics, which, on the basis of epidemiological evidence, is known to be associated with CARDIOVASCULAR DISEASES and TYPE 2 DIABETES MELLITUS.
] |
|
Cardiomyopathies
|
D009202 |
[A group of diseases in which the dominant feature is the involvement of the CARDIAC MUSCLE itself. Cardiomyopathies are classified according to their predominant pathophysiological features (DILATED CARDIOMYOPATHY; HYPERTROPHIC CARDIOMYOPATHY; RESTRICTIVE CARDIOMYOPATHY) or their etiological/pathological factors (CARDIOMYOPATHY, ALCOHOLIC; ENDOCARDIAL FIBROELASTOSIS).
] |
|
Cardiomyopathy, Alcoholic
|
D002310 |
[Disease of CARDIAC MUSCLE resulting from chronic excessive alcohol consumption. Myocardial damage can be caused by: (1) a toxic effect of alcohol; (2) malnutrition in alcoholics such as THIAMINE DEFICIENCY; or (3) toxic effect of additives in alcoholic beverages such as COBALT. This disease is usually manifested by DYSPNEA and palpitations with CARDIOMEGALY and congestive heart failure (HEART FAILURE).
] |
|
Cardiomyopathy, Dilated
|
D002311 |
[A form of CARDIAC MUSCLE disease that is characterized by ventricular dilation, VENTRICULAR DYSFUNCTION, and HEART FAILURE. Risk factors include SMOKING; ALCOHOL DRINKING; HYPERTENSION; INFECTION; PREGNANCY; and mutations in the LMNA gene encoding LAMIN TYPE A, a NUCLEAR LAMINA protein.
] |
|
Cardiomyopathy, Hypertrophic
|
D002312 |
[A form of CARDIAC MUSCLE disease, characterized by left and/or right ventricular hypertrophy (HYPERTROPHY, LEFT VENTRICULAR; HYPERTROPHY, RIGHT VENTRICULAR), frequent asymmetrical involvement of the HEART SEPTUM, and normal or reduced left ventricular volume. Risk factors include HYPERTENSION; AORTIC STENOSIS; and gene MUTATION; (FAMILIAL HYPERTROPHIC CARDIOMYOPATHY).
] |
|
Cardiomyopathy, Hypertrophic, Familial
|
D024741 |
[An autosomal dominant inherited form of HYPERTROPHIC CARDIOMYOPATHY. It results from any of more than 50 mutations involving genes encoding contractile proteins such as VENTRICULAR MYOSINS; cardiac TROPONIN T; ALPHA-TROPOMYOSIN.
] |
|
Cardiomyopathy, Restrictive
|
D002313 |
[A form of CARDIAC MUSCLE disease in which the ventricular walls are excessively rigid, impeding ventricular filling. It is marked by reduced diastolic volume of either or both ventricles but normal or nearly normal systolic function. It may be idiopathic or associated with other diseases (ENDOMYOCARDIAL FIBROSIS or AMYLOIDOSIS) causing interstitial fibrosis.
] |
|
Cardiomyoplasty
|
D018421 |
[An operation that uses stimulated latissimus dorsi muscle (SKELETAL MUSCLE VENTRICLE) to assist cardiac function. The latissimus dorsi muscle is mobilized from the chest wall and moved into the thorax through the bed of the resected 2nd or 3rd rib. The muscle is then wrapped around the left and right ventricles and stimulated to contract during cardiac systole by means of an implanted burst-stimulator. (Stedman, 26th ed)
] |
|
Cardioplegic Solutions
|
D002314 |
[Solutions which, upon administration, will temporarily arrest cardiac activity. They are used in the performance of heart surgery.
] |
|
Cardiopulmonary Bypass
|
D002315 |
[Diversion of the flow of blood from the entrance of the right atrium directly to the aorta (or femoral artery) via an oxygenator thus bypassing both the heart and lungs.
] |
|
Cardiopulmonary Resuscitation
|
D016887 |
[The artificial substitution of heart and lung action as indicated for HEART ARREST resulting from electric shock, DROWNING, respiratory arrest, or other causes. The two major components of cardiopulmonary resuscitation are artificial ventilation (RESPIRATION, ARTIFICIAL) and closed-chest CARDIAC MASSAGE.
] |
|
Cardiorespiratory Fitness
|
D000072599 |
[A measure of the functional capabilities of the heart, lungs and muscles, relative to the demands of specific exercise routines such as running or cycling.
] |
|
Cardiotocography
|
D015148 |
[Monitoring of FETAL HEART frequency before birth in order to assess impending prematurity in relation to the pattern or intensity of antepartum UTERINE CONTRACTION.
] |
|
Cardiotonic Agents
|
D002316 |
[Agents that have a strengthening effect on the heart or that can increase cardiac output. They may be CARDIAC GLYCOSIDES; SYMPATHOMIMETICS; or other drugs. They are used after MYOCARDIAL INFARCT; CARDIAC SURGICAL PROCEDURES; in SHOCK; or in congestive heart failure (HEART FAILURE).
] |
